Eli Lilly-backed Lycia fuels up on VC cash in a discovery drive toward protein degradation 2.0

Just weeks after nabbing a marquee alliance with Eli Lilly, the pharma giant has come back to support a $70 million B round for Lycia Therapeutics designed to fund the next stage of discovery at the protein degradation player.

Founder Versant Ventures also came back to add to the...

Click to view original post